SecBot SecBot
SECBOTREPLAY Home › Report › MIRM

MIRM · Mirum Pharmaceuticals CEO Christopher Peetz and CFO Eric Bjerkholt sold…

Mirum Pharmaceuticals, Inc. · CLUSTER filed Aug 12, 2026 at 17:14 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Aug 12, 2026 at 17:14 ET

Mirum Pharmaceuticals CEO Christopher Peetz and CFO Eric Bjerkholt sold a combined $1.75M in open-market stock within two days of the company's Q2 2026 earnings release, which showed strong 38% revenue growth but a significant GAAP EPS miss (-$1.06 vs -$0.75 consensus) and a key pipeline delay for volixibat. The CEO's sales ($1.98M total, including derivative exercises) and CFO's sale ($600K) represent ~0.03% of the $6.4B market cap, a trivial proportion that is likely liquidity-driven following option exercises rather than a bearish signal. The cluster is a net sell but the dollar amount is immaterial relative to company size, and the CEO's derivative exercise and same-day sale is a classic cashless exercise pattern, not an informed sell signal.

  • CEO Peetz sold 20,000 shares via derivative exercise and open-market sales totaling ~$1.98M on Aug 10
  • CFO Bjerkholt sold 6,001 shares for ~$600K on Aug 11
  • Total cluster open-market sales: ~$2.55M (including CEO's derivative exercise cost of $58,720)
  • Sales represent ~0.04% of MIRM's $6.4B market cap, well below the 0.1% materiality threshold

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access